30 Member Networks and Programs Receive Commendations in 2021 for Outstanding Research Performance

Doctor conducing skin exam
Trial Spotlight: Ravi Amaravadi on the EA6191/BAMM2 Trial for Melanoma
November 16, 2021
Young patient and doctor with laptop
Now Enrolling: EAQ202 to Improve Adolescent and Young Adult Self-Reported Data
November 16, 2021

30 Member Networks and Programs Receive Commendations in 2021 for Outstanding Research Performance

Evaluation Form

Each year, the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) conducts an Institution Evaluation in which a subset of Principal Investigator (PI) Committee members and senior administrators meet to evaluate the performance of ECOG-ACRIN member networks and programs. The exceptional staff in the Membership Department facilitates the process—encompassing nearly 1500 individual research institutions in total, comprising 140 research programs. Through this annual review, principal investigators and research personnel stay informed about the many scientific and administrative components that comprise ECOG-ACRIN's expectations for retaining membership in the Group. In addition, the evaluation ensures that member institutions maintain ECOG-ACRIN's high standards to conduct cancer research with and through the Group.

Data from the previous calendar year is evaluated, 2020 in this case. The following areas are part of the review: accrual, clinical data quality and timeliness, compliance with requirements for submission of laboratory samples and images; scientific leadership, administrative contribution, and compliance with policies of both ECOG-ACRIN and the National Cancer Institute through its National Clinical Trials Network (NCTN) audit process. The review committee is blinded to the identity of the institutions during this initial evaluation when they give a numerical rating to these categories. However, final unblinded assessments are based on both the objective data and discussions on the unique aspects of each institution that cannot be captured in a numerical rating.

For 2021, the review committee voted to commend the following 30 networks and programs for outstanding performance. Group Co-Chairs Peter O'Dwyer, MD, and Mitchell Schnall, MD, PhD, recognized these sites during the General Session of the Virtual Fall 2021 Group Meeting in October.

Members Recognized in 2021 for Outstanding Performance

Institution Principal Investigator
Aurora NCORP Thomas J. Saphner, MD
Altman Health Foundation Sunitha Vemulapalli, MD
Carle Cancer Center NCORP ** Kendrith M. Rowland, MD
CERIM (Argentina) Daniel E. Lehrer, MD
Duke University/Duke Cancer Institute * Daniel P. Barboriak, MD
Essentia Health NCORP * Bret B. Friday, MD
Fox Chase Cancer Center * Lori J. Goldstein, MD
Fred Hutchinson Cancer Research Center * Evan Ya-Wen Yu, MD
Georgia NCORP * Howard A. Zaren, MD
Gulf South Minority Underserved NCORP Augusto C. Ochoa, MD
Heartland Cancer Research NCORP Bryan A. Faller, MD
Indiana University/Melvin and Bren Simon Cancer Center * Kathy D. Miller, MD
Mayo Clinic Cancer Center Thomas M. Habermann, MD
Medical College of Wisconsin Timothy S. Fenske, MD, MS
Memorial Sloan Kettering Cancer Center Christopher E. Comstock, MD
Metro Minnesota Community Oncology Research Consortium David M. King, MD
National Capital Area Minority Underserved NCORP + Geoffrey T. Gibney, MD
Pacific Cancer Research Consortium NCORP Gary E. Goodman, MD
Rutgers Cancer Institute of New Jersey * Howard S. Hochster, MD
Thomas Jefferson University/Sidney Kimmel Cancer Center * Edith P. Mitchell, MD
University of Massachusetts Memorial Medical Center Jan Cerny, MD
University of North Carolina at Chapel Hill/Lineberger Comprehensive Cancer Center * Lisa A. Carey, MD
University of Pennsylvania/Penn Medicine Abramson Cancer Center Jennifer R. Eads, MD
Upstate Carolina NCORP + James Bearden III, MD
The University of Texas/MD Anderson Cancer Center * PI in transition
The University of Texas Southwestern/Harold C. Simmons Comprehensive Cancer Center * David E. Gerber, MD
Vanderbilt University/Vanderbilt-Ingram Cancer Center Jordan D. Berlin, MD
Washington University at St. Louis/Siteman Cancer Center Barry A. Siegel, MD
Wisconsin NCORP Kurt R. Oettel, MD
Yale University/Yale Cancer Center Barbara A. Burtness, MD

** Commended for Accrual and Data Quality
* Commended for Accrual
+ New Provisional Member

Visit ecog-acrin.org to learn more about ECOG-ACRIN's flexible Membership Program and obtain details in the Group constitution.

Leave a Reply

Your email address will not be published. Required fields are marked *